Quaero Life Science Phase II started

  

The second phase project of Quaero Life Science in Jiaxing Science and Technology City started with a planned total investment of 440 million.

The new site is located on west of Xingye Road and north of Xinbei Road in the Industrial Acceleration Demonstration Zone of Jiaxing Science and Technology City，new construction area is 108365.83 square meters. The total investment of the project plan is 441.3239 million. A new medical device CDMO R&D center, instrument and consumables production base will be built. Production products include 3,000 sets of IVD medical instruments and 3 billion medical consumables.

Deputy Director of Jiaxing Science and Technology City Management Committee delivered a speech at the groundbreaking ceremony. Deputy Director said, Jiaxing Science and Technology City is the fertile ground for Quaero to grow, and from here Quaero will go to the whole country and become the leader of the industry. Growing from a seedling to a giant tree, Jiaxing Science and Technology City has nurtured a large number of talented enterprises goes to public. At present, three enterprises have been successfully went to public, and five enterprises have entered the stage of listing stock reform. In the next five years, Jiaxing Science and Technology City will have one or two companies went to public each year. After the project starts, hope that all departments will fully support the construction with higher efficiency, better policies and faster response, do a good job in guaranteeing the work, and make joint efforts to promote the early completion, early commissioning and early performance of the project.

　Biomedicine is a national strategic emerging industry, in recent years, Jiaxing Science and Technology City has vigorously introduced a number of biomedical enterprises, most of them are leading talent enterprises. Quaero Life Science is one of them. Quaero Life Science is devoted to providing fully automated, intelligent solutions for IVD industry. After more than 10 years of development, Quaero has become the major CDMO company in Chinese IVD instruments industry. In the first half of this year, Quaero achieved a year-on-year revenue growth of 84.38%, and has now completed its share reform and entered the echelon of listed companies.

　　The chairman of Quaero Life Science Mr. Ben Huang said, ‘New projects will provide a larger stage for growth in the next 5 years，We will continue to invest in all aspects including core technology, lean manufacturing, and talent acquisition. Take ‘Careful as Walking on Eggshells’ as our attitude to continue to build the platform, fill the shortcomings, and strive for innovation; to provide better life sciences products and services for the domestic and international markets’.

　　In the second half of this year，Quaero has been listed on the key ‘Small Giant’ enterprises announced by Ministry of Industry and Information Technology(MIIT). National Key ‘Small Giant’ enterprises are selected from the Ministry of Industry and Information Technology (MIIT)'s recognized "Small Giant" enterprises with special characteristics. MIIT will support key ‘Small Giant’ enterprises to increase innovation investment, and enhance the development potential and international competitiveness of enterprises.

　　In recent years, Quaero has grown rapidly as the following development process：2012，Certified as the National High-tech Enterprise；2014 Launched of Light initiated Chemiluminescence Assay；2015，Company found Mr. Ben Huang was awarded the National "Ten Thousand People Plan" Innovation and Entrepreneurship Talent Award；2019，Received the provincial first set of product recognition; Once again received major provincial and municipal science and technology special project support；2020，Awarded Zhejiang Enterprise Research Institute and Zhejiang ‘invisible’ Champion Cultivation.

  

Back